Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC

K. Musick,J. Howard,G. Li,T. Vu, D. Korobko,M. Smilowski, L. Liu,S. Steeland, J. Noukens, B. Van Hoorick,J. Podhorna, Y. Li,K. Utsugisawa,F. Sacca,H. Wiendl,J. De Bleecker,R. Mantegazza

NEUROLOGY(2023)

引用 0|浏览2
暂无评分
关键词
generalized myasthenia gravis,subcutaneous efgartigimod ph20,long-term
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要